Sunshine Biopharma Inc. (SBFMW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

-3.5M 0 3.5M 7M 10.5M Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 91.2K Q2 '18: 0 Q3 '18: 0 Q4 '18: -91.2K Q1 '19: 206 Q2 '19: 3K Q3 '19: 7.3K Q4 '19: 10.6K Q1 '20: 11.1K Q2 '20: 15.1K Q3 '20: 17.1K Q4 '20: 28K Q1 '21: 40.1K Q2 '21: 52.9K Q3 '21: 50.4K Q4 '21: 85.1K Q1 '22: 122.6K Q2 '22: 150.3K Q3 '22: 132.8K Q4 '22: 3.9M Q1 '23: 4.9M Q2 '23: 5.6M Q3 '23: 6M Q4 '23: 7.7M Q1 '24: 7.5M Q2 '24: 9.3M Q3 '24: 8.4M Q4 '24: 9.6M Q1 '25: 8.9M Q2 '25: 9.4M Q3 '25: 9.4M Q4 '25: 8.6M Q1 '26: 8.1M Q2 '26: 9.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

-1.5M 0 1.5M 3M 4.5M Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: -9.7K Q2 '18: 0 Q3 '18: 0 Q4 '18: 9.7K Q1 '19: 94 Q2 '19: 1.6K Q3 '19: 2K Q4 '19: 6.4K Q1 '20: 7.2K Q2 '20: 10K Q3 '20: 10.8K Q4 '20: 17.6K Q1 '21: 21.5K Q2 '21: 34.4K Q3 '21: 30.9K Q4 '21: 23.8K Q1 '22: 62.8K Q2 '22: 75.6K Q3 '22: 67K Q4 '22: 1.5M Q1 '23: 1.8M Q2 '23: 2M Q3 '23: 2M Q4 '23: 2.6M Q1 '24: 2.4M Q2 '24: 2.4M Q3 '24: 2.9M Q4 '24: 3.1M Q1 '25: 2.7M Q2 '25: 3.4M Q3 '25: 3.1M Q4 '25: 3M Q1 '26: 2.2M Q2 '26: 2.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '16: -116K Q4 '16: -336.1K Q1 '17: -109K Q2 '17: -472.2K Q3 '17: -113.8K Q4 '17: -162.2K Q1 '18: -166.7K Q2 '18: -580.5K Q3 '18: -288.8K Q4 '18: -143.7K Q1 '19: -122.2K Q2 '19: -66.2K Q3 '19: -202.6K Q4 '19: -250.6K Q1 '20: -37.7K Q2 '20: -128.6K Q3 '20: -67.3K Q4 '20: -343.3K Q1 '21: -1.3M Q2 '21: -388.6K Q3 '21: -496.3K Q4 '21: -279.6K Q1 '22: -1.2M Q2 '22: -695.8K Q3 '22: -1.7M Q4 '22: -23.4M Q1 '23: -1.8M Q2 '23: -1M Q3 '23: -779.5K Q4 '23: -1.2M Q1 '24: -1.4M Q2 '24: -1.3M Q3 '24: -1.1M Q4 '24: -2M Q1 '25: -1.3M Q2 '25: -2.1M Q3 '25: -1.1M Q4 '25: -1.8M Q1 '26: -1.4M Q2 '26: -1.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '16: -1.6M Q4 '16: -1.1M Q1 '17: -195.7K Q2 '17: -485.4K Q3 '17: -147.6K Q4 '17: -211.5K Q1 '18: -265.6K Q2 '18: -644.3K Q3 '18: -907.6K Q4 '18: -338.7K Q1 '19: -202.5K Q2 '19: -710.9K Q3 '19: -350.2K Q4 '19: -396.6K Q1 '20: -94.3K Q2 '20: -907.4K Q3 '20: -698.6K Q4 '20: -1.1M Q1 '21: -6.2M Q2 '21: -2.9M Q3 '21: -4M Q4 '21: 646.8K Q1 '22: -1.2M Q2 '22: -538.9K Q3 '22: -1.5M Q4 '22: -23.5M Q1 '23: -1.7M Q2 '23: -902.1K Q3 '23: -651.5K Q4 '23: -1.3M Q1 '24: -1.3M Q2 '24: -494.3K Q3 '24: -1.2M Q4 '24: -2.2M Q1 '25: -1.2M Q2 '25: -1.8M Q3 '25: -883.8K Q4 '25: -2.1M Q1 '26: -1.2M Q2 '26: -1.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

-2.5M 0 2.5M 5M 7.5M Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 100.8K Q2 '18: 0 Q3 '18: 0 Q4 '18: -100.8K Q1 '19: 112 Q2 '19: 1.5K Q3 '19: 5.3K Q4 '19: 4.2K Q1 '20: 3.9K Q2 '20: 5.2K Q3 '20: 6.3K Q4 '20: 10.5K Q1 '21: 18.5K Q2 '21: 18.5K Q3 '21: 19.5K Q4 '21: 61.3K Q1 '22: 59.8K Q2 '22: 74.7K Q3 '22: 65.8K Q4 '22: 2.4M Q1 '23: 3.1M Q2 '23: 3.6M Q3 '23: 4M Q4 '23: 5.1M Q1 '24: 5.2M Q2 '24: 6.9M Q3 '24: 5.6M Q4 '24: 6.5M Q1 '25: 6.2M Q2 '25: 6M Q3 '25: 6.3M Q4 '25: 5.5M Q1 '26: 5.9M Q2 '26: 6.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '16: -63K Q4 '16: -31.2K Q1 '17: -108K Q2 '17: -77.8K Q3 '17: -148.2K Q4 '17: -209.5K Q1 '18: -168.5K Q2 '18: -57.4K Q3 '18: -170.9K Q4 '18: -116K Q1 '19: -234K Q2 '19: -47.5K Q3 '19: -86.5K Q4 '19: -127.8K Q1 '20: -31K Q2 '20: -82K Q3 '20: -120.6K Q4 '20: -423.7K Q1 '21: -297.4K Q2 '21: -618.9K Q3 '21: -600.8K Q4 '21: -312.1K Q1 '22: -1.3M Q2 '22: -573.8K Q3 '22: -1.1M Q4 '22: -2.2M Q1 '23: -1.9M Q2 '23: -3.8M Q3 '23: -457.3K Q4 '23: -2.7M Q1 '24: -3.2M Q2 '24: -4.6M Q3 '24: -1.4M Q4 '24: -3.4M Q1 '25: -1.7M Q2 '25: -1.3M Q3 '25: -746.7K Q4 '25: -1.6M Q1 '26: -2.1M Q2 '26: -918K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '16: -81.6K Q2 '16: -140.7K Q3 '16: -63K Q4 '16: -32.3K Q1 '17: -108K Q2 '17: -100.1K Q3 '17: -170.5K Q4 '17: -213.2K Q1 '18: -173.2K Q2 '18: -75K Q3 '18: -175.9K Q1 '19: -234K Q2 '19: -47.9K Q3 '19: -87K Q4 '19: -128.7K Q3 '20: -121.4K Q4 '20: -424.1K Q4 '21: -312.1K Q3 '22: -1.1M Q4 '22: -2.4M Q3 '23: -466.9K Q1 '24: -3.2M Q2 '24: -5.6M Q3 '24: -1.9M Q4 '24: -3.5M Q1 '25: -1.7M Q2 '25: -1.4M Q3 '25: -754.7K Q4 '25: -1.6M Q1 '26: -2.1M Q2 '26: -925K Q3 '16 Q3 '17 Q3 '18 Q4 '19 Q3 '22 Q2 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 350M 700M 1.1B Q2 '13: 56.6M Q3 '13: 56.9M Q1 '14: 61.1M Q2 '14: 65.5M Q3 '14: 67.8M Q1 '15: 64.7M Q2 '15: 119.9M Q3 '15: 130.1M Q1 '16: 215.6M Q2 '16: 262.4M Q3 '16: 262.4M Q1 '17: 805.6M Q2 '17: 857.5M Q3 '17: 907.7M Q1 '18: 47.1M Q2 '18: 50M Q3 '18: 50M Q1 '19: 4.3M Q2 '19: 5M Q3 '19: 8.3M Q1 '20: 37.6M Q2 '20: 153.1M Q3 '20: 280.9M Q1 '21: 2.2M Q2 '21: 2.4M Q3 '21: 2.5M Q1 '22: 5.3M Q2 '22: 15.8M Q3 '22: 18.9M Q1 '23: 220.4K Q2 '23: 12.7K Q3 '23: 12.8K Q1 '24: 641.3K Q2 '24: 40.9K Q3 '24: 1.3M Q1 '25: 2.7M Q2 '25: 3.6M Q3 '25: 4.6M Q1 '26: 4.9M Q2 '26: 1.4M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-240.00 -160.00 -80.00 0.00 80.00 160.00 240.00 Q1 '15: -0.02 Q2 '15: -0.01 Q3 '15: -0.01 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: -0.01 Q4 '16: -0.01 Q1 '17: -0.01 Q2 '17: -0.01 Q3 '17: 0.00 Q4 '17: -0.02 Q1 '18: -0.02 Q2 '18: -0.03 Q3 '18: -0.05 Q4 '18: -0.70 Q1 '19: -0.75 Q2 '19: -0.88 Q3 '19: -0.90 Q4 '19: -0.15 Q1 '20: -0.10 Q2 '20: 0.03 Q3 '20: 0.07 Q4 '20: -2.73 Q1 '21: -5.55 Q2 '21: -6.75 Q3 '21: -8.34 Q4 '21: -4.76 Q1 '22: -2.17 Q2 '22: -0.99 Q3 '22: 0.68 Q4 '22: -2.20 Q1 '23: -9.70 Q2 '23: -80.84 Q3 '23: -131.64 Q4 '23: -215.27 Q1 '24: -209.54 Q4 '25: -1.44 Q1 '26: -1.25 Q2 '26: -1.58 Q1 '16 Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.